OVERVIEW

Cedars-Sinai Pioneers in Medicine-Ep. 01: Recognizing the Risk of Pulmonary Embolism is organized by Cedars-Sinai Medical Center.

Release Date: Mar 02, 2021
Expiry Date: Mar 01, 2022

Target Audience:
Specialties - Cardiology, Critical Care Medicine, Emergency Medicine, Endocrinology & Metabolism, Family / General Medicine, Gastroenterology, Geriatrics, Hematology, Imaging, Infectious Disease, Internal Medicine, Medical Genetics, Nephrology, Neurology, Neurosurgery, Obstetrics & Gynecology, Oncology, Orthopaedic Surgery, Pathology & Laboratory Medicine, Pediatrics, Plastic Surgery, Preventive Medicine, Psychiatry, Pulmonary Medicine, Radiology, Rheumatology, Surgery, Thoracic Surgery, Transplant Surgery, Urology, Vascular Medicine, Vascular Surgery

Overview:
The “Pioneers in Medicine” interview podcast series will present short conversations with internationally recognized leaders, who care for patients at Cedars-Sinai, and will discuss advances in the field through path breaking research. Approximately 100,000 patients in the U.S. die each year from pulmonary embolism (PE), according to Victor Tapson, MD, professor of Medicine, associate director of Pulmonary and Critical Care and director of the Venous Thromboembolism Research Program at Cedars-Sinai. While the ability to diagnose PE and deep venous thrombosis (DVT) has gotten better with new techniques and sharper CT scans, patients are still often not suspected of having the condition until it’s too late. In this “Pioneers in Medicine” interview, Tapson talks with host Bruce L. Gewertz, MD, Surgeon-In-Chief, H&S Nichols Distinguished Chair in Surgery and Vice Dean, Academic Affairs, about the patient population, risks and treatment options.